The pharmaceutical industry is an intricate web of innovation, research, and development, working tirelessly to bring groundbreaking therapies to patients…
Implications of 2seventy Bio’s Paused CAR-T Leukemia Trial
With the exponential rise of novel treatment modalities in oncology, cell therapies like CAR-T (Chimeric Antigen Receptor T-cell) have been…
FDA Grants Approval to Lexicon Pharma’s Heart Failure Drug
Lexicon Pharmaceuticals, a pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for its heart failure…
FDA Advisers Evaluate Sarepta’s Duchenne Gene Therapy
FDA advisers are currently undertaking a careful evaluation of Sarepta’s Duchenne gene therapy, a groundbreaking treatment that holds immense potential…
Ozempic: From Weight Loss to Alzheimer’s Treatment
Ozempic: From Weight Loss to Alzheimer’s Treatment Following its success as a weight loss drug, Ozempic is now being explored…
Promising Results: Eli Lilly’s Experimental Drug Delays Alzheimer’s Progression
Alzheimer’s disease is a progressive brain disorder that affects memory, thinking, and behavior. It is the most common cause of…
Ascendis’ Hormone Disorder Therapy Fails to Win Approval from US FDA
Ascendis Pharma has announced that its hormone disorder therapy has failed to win approval from the US Food and Drug…